Sign in

CIK 0001636282

  • Large accelerated filer

Spyre Therapeutics, Inc.

Sign in to watch
Ticker
SYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464312787
Phone
+1 617-651-5940
Business address
221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aeglea BioTherapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$12,349,597
in 6 filings, $12.3M under 10b5-1 plans

Net −$12,349,597. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 21 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-02-14 Sloan Leslie Chief Operating Officer Grant or award · Employee Stock Option (right to buy) +100,000 100,000
2020-02-14 Rao Madduri Ravin Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +25,000 25,000
2020-02-14 Quinn Anthony G. President & CEO Grant or award · Employee Stock Option (right to buy) +301,000 301,000
2020-02-14 Hanley Jr. Michael Conick Chief Commercial Officer Grant or award · Employee Stock Option (right to buy) +25,000 25,000
2019-11-01 Rao Madduri Ravin Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +130,000 130,000
2019-10-21 Hanley Jr. Michael Conick Chief Commercial Officer Grant or award · Employee Stock Option (right to buy) +130,000 130,000
2019-10-04 Quinn Anthony G. President & CEO Option exercise +662 $5.46 $4K 354,305
2019-10-04 Quinn Anthony G. President & CEO Option exercise +17,603 $6.31 $111K 371,908
2019-10-04 Quinn Anthony G. President & CEO Option exercise · Stock Option (right to buy) −662 0
2019-10-04 Quinn Anthony G. President & CEO Option exercise · Stock Option (right to buy) −17,603 119,914
2019-06-14 Quinn Anthony G. President & CEO Purchase +5,282 $6.23 $33K 353,643
2019-06-13 Quinn Anthony G. President & CEO Purchase +14,406 $6.17 $89K 348,361
2019-06-12 Quinn Anthony G. President & CEO Purchase +12,217 $6.11 $75K 333,955
2019-06-07 LAWLIS V BRYAN Director Grant or award · Director Stock Option (right to buy) +12,400 12,400
2019-06-07 Shanafelt Armen Director Grant or award · Director Stock Option (right to buy) +12,400 12,400
2019-06-07 Mahatme Sandesh Director Grant or award · Director Stock Option (right to buy) +12,400 12,400
2019-06-07 Magovcevic Ivana Director Grant or award · Director Stock Option (right to buy) +12,400 12,400
2019-06-07 Cox Russell J. Director Grant or award · Director Stock Option (right to buy) +12,400 12,400
2019-06-07 Bruhn Suzanne Louise Director Grant or award · Director Stock Option (right to buy) +12,400 12,400
2019-05-22 Quinn Anthony G. President & CEO Purchase +3,809 $6.86 $26K 321,738

Page 14 of 19 · 372 trades